Tooth enamel hydroxyapatite (HAP) and dental plaque mineral matrix (HAP)

Tooth enamel hydroxyapatite is the primary inorganic constituent of human teeth, forming a highly organized crystalline lattice (Ca10(PO4)6(OH)2) that provides the necessary hardness for mastication and protects the underlying dentin and pulp (StatPearls: NBK513314). The dental plaque mineral matrix represents the inorganic component of the oral biofilm, which can sequester calcium and phosphate ions, eventually leading to the formation of dental calculus or tartar (PMC: 6169526). These mineralized structures are central to the pathogenesis of dental caries and periodontal disease, as the balance between demineralization and remineralization determines the health of the tooth surface (PubMed: 29193903). Pharmacological interventions often target these matrices to enhance structural integrity or prevent pathological calcification. For instance, fluoride-containing agents promote the formation of fluorapatite within the enamel, which is significantly more resistant to acid attacks from cariogenic bacteria than the original hydroxyapatite (NIH: Fluoride Fact Sheet). Additionally, anti-calculus agents like pyrophosphates are designed to inhibit the crystallization of the plaque mineral matrix, thereby reducing the accumulation of hard deposits that contribute to gingival inflammation (PMC: 6169526).

Other names

Calcium hydroxyapatiteTooth mineralDental calculus matrixBioapatiteCrystalline calcium phosphate

Fluoride ions substitute for hydroxyl groups in the hydroxyapatite lattice to form fluorapatite, which has a lower solubility product and higher resistance to acid-induced demineralization (PubMed: 29193903). Remineralizing agents provide a supersaturated environment of calcium and phosphate ions to repair the mineral matrix, while crystal growth inhibitors like pyrophosphates bind to the plaque matrix to prevent calcification into calculus (PMC: 6169526).